The medication also slows gastric emptyingthe rate at which food moves from your stomach into your intestines
A: Most patients tolerate GLP-1s very well
Even in this more challenging population, the combination produced 13.7% weight reduction versus 3.4% for placebo, along with dramatic improvements in glycemic control
Understanding why it happens and what you can do about it is the first step toward regaining confidence and control
Researchers are currently investigating the potential of liraglutide in the management of PCOS, NAFLD, psoriasis, Alzheimer's, Parkinson's, and other chronic debilitating diseases
It is currently approved for type 2 diabetes control as well as reducing the risk of cardiovascular events in T2D patients